Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Roivant Sciences Ltd (ROIV)

Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Roivant Sciences Ltd 7th Floor 50 Broadway LONDON X0 SW1H 0DB GBR

https://roivant.com Employees: 908 P: 44-20-7400-3347

Description:

Roivant Sciences is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. Roivant Sciences, formerly known as Montes Archimedes Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 8,332,784
Enterprise Value, $K 2,239,664
Shares Outstanding, K 738,722
Annual Sales, $ 124,800 K
Annual Net Income, $ 4,349 M
Last Quarter Sales, $ 55,130 K
Last Quarter Net Income, $ 95,300 K
EBIT, $ 4,398 M
EBITDA, $ 4,420 M
60-Month Beta 1.24
% of Insider Shareholders 4.60%
% of Institutional Shareholders 64.76%
Float, K 704,741
% Float 95.40%
Short Volume Ratio 0.64

Growth:

1-Year Return 7.58%
3-Year Return 74.88%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 08/08/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -1.11
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year 36.84%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ROIV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -17.23%
Return-on-Assets % -15.11%
Profit Margin % 3,484.72%
Debt/Equity 0.05
Price/Sales 67.38
Price/Cash Flow N/A
Price/Book 1.45
Book Value/Share 7.98
Interest Coverage 123.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar